Drs. Scott Halpern and Ezekiel Emanuel from the Department of Medical Ethics & Health Policy at the Perelman School of Medicine at the University of Pennsylvania offer five points of guidance on the use of life-sustaining therapies for patients with Ebola in developed countries in an article published in Annals of Internal Medicine.
As hospital administrators in the developed world prepare to care for Ebola patients, they must consider several unfamiliar and challenging ethical and operational questions. The recommendations are intended to help institutions develop policies that balance risks, benefits, and duties to patients with Ebola and volunteer clinicians.